Presentation ACC 2012 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-Month Dual Antiplatelet Therapy Following Zotarolimus-Eluting Stent Implantation: RESET Trial Presenter: Myeong-Ki Hong March 25, 2012
Presentation ACC 2012 Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Ischemic Heart Failure: The FOCUS-CCTRN Trial Presenter: Emerson C. Perin March 25, 2012
Presentation ACC 2012 A Double Blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis Presenter: Antonio Colombo March 25, 2012
Presentation ACC 2012 2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Presenter: Laura Mauri March 25, 2012
Presentation ACC 2012 RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel Presenter: Gennaro Sardella March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
Presentation ACC 2012 Long-Term Outcomes Following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience Presenter: Josep Rod?s-Cabau March 24, 2012
Presentation ACC 2012 Economic Impact of Transradial Percutaneous Coronary Intervention Presenter: David Safley March 24, 2012
Presentation Balloon-pump assisted Coronary Intervention Study (BCIS-1): Long term Mortality Data Presenter: 130910|Divaka Perera March 24, 2012
Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012